Allecra Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALLECRA THERAPS, and what generic alternatives to ALLECRA THERAPS drugs are available?
ALLECRA THERAPS has one approved drug.
There are two US patents protecting ALLECRA THERAPS drugs.
There are twenty-one patent family members on ALLECRA THERAPS drugs in eighteen countries.
Drugs and US Patents for Allecra Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allecra Theraps | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Allecra Theraps | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Allecra Theraps | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | 11,124,526 | ⤷ Subscribe | ⤷ Subscribe | ||||
Allecra Theraps | EXBLIFEP | cefepime hydrochloride; enmetazobactam | POWDER;INTRAVENOUS | 216165-001 | Feb 22, 2024 | DISCN | Yes | No | 7,687,488 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Allecra Theraps Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Eurasian Patent Organization | 031348 | ⤷ Subscribe |
European Patent Office | 2046802 | ⤷ Subscribe |
Japan | 2021102642 | ⤷ Subscribe |
Portugal | 2046802 | ⤷ Subscribe |
Japan | 2016535054 | ⤷ Subscribe |
Denmark | 2046802 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.